Navigation Links
Nonin Medical Inc. Announces Entry Into the Cerebral Oximeter Market
Date:7/22/2008

MINNEAPOLIS, July 22 /PRNewswire/ -- Nonin Medical, a leading innovator of physiological monitoring solutions for more than 20 years, has entered the clinical testing phase with its breakthrough technology to measure regional oxygen saturation. Today's most common application for this technology is the continuous monitoring of the regional blood oxygenation in the brain -- cerebral oximetry.

Early testing data and outcomes from an ongoing clinical study at the Duke University Medical Center have yielded favorable results. These data results support the objective to simplify sensor application while improving the usefulness of the measurement.

For over two decades, Nonin Medical has remained at the forefront of noninvasive physiological monitoring with specific focus on highly effective signal processing and the advancement of innovative pulse oximeter products. With the introduction of the Onyx(R), the world's first fingertip pulse oximeter, Nonin Medical changed the global market for oximetry. Today, Nonin Medical has the largest installed base of pulse oximeters in the industry with well over one million units worldwide.

"This invaluable clinical and technical experience combined with a vision for the future has enabled us to develop a product that promises to advance the field of patient monitoring, once again," said Gary Tschautscher, CEO and President of Nonin Medical. "We understand the immense pressure on the healthcare market to reduce the cost of patient care while providing new, more effective, yet simple solutions. Our newly developed sensor and patented signal processing technology is designed to deliver on these objectives."

The advanced modular design of this new technology permits future expansion of functionality, while also permitting product and data integration into other monitoring systems. This clearly aligns with Nonin Medical's vision for interoperability and facilitating information flow without the need of
'/>"/>

SOURCE Nonin Medical
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related medicine technology :

1. Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis
2. New Research Shows Masimo Perfusion Index (PI) Effective in the Noninvasive Detection of Congenital Heart Defects (CHD) in Newborns
3. MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion
4. Rosetta Genomics and Rabin Medical Center Announce a Collaboration Focused on MicroRNA-Based Diagnostics
5. Intellect Neurosciences, Inc. and Medical Research Council Technology (U.K.) Reach Important Milestone in Generating an Alzheimers Therapeutic Antibody
6. Advocate Christ Medical Center Using Glue-Like Liquid to Seal Off Brain Aneurysms
7. The Foundation for Biomedical Research Announces Winners of the 7th Annual Michael E. DeBakey Journalism Awards
8. Synapse Biomedical Receives FDA Approval of NeuRx Diaphragm Pacing System (DPS)(TM) For Spinal Cord Injury Breathing Applications
9. Saladax Biomedicals 5-FU Personalized Chemotherapy Management (PCM(R)) Assay CE Marked for Distribution in the EU
10. Oridion Announces Major Medical Research and Congress Presentations
11. Fox Chase Cancer Center and VisEn Medical Announce Program to Advance First Clinical Trials of Novel Fluorescence Molecular Imaging Technologies

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... MARLTON, N.J., Dec. 4 Thermograph...; Wellness Center in Marlton, New Jersey continues...he breast, neuromuscular system, thyroid, dental, ...osis of problems associated with these areas. ,...that "read" the entire infrared range of the elect...
(Date:12/4/2009)...FREMONT, Calif., Dec. 4 ...nced that on December 3, 2009, it filed its First ... Disclosure Statement with the United States Bankr...A hearing to consider the adequacy of the Disclosu..., 2009, with the hearing on the confirmation of th...
(Date:12/4/2009)... Workers Ensure Emergency Deliveries are Transport...wire/ -- Teamster members employed by the Philadel... work educating the public about the unfair labor ... put Philadelphia,s blood supply at risk. More th...t line yesterday when their issues were ignored by...
Breaking Medicine Technology:Discover Health Through Awareness 2Discover Health Through Awareness 3Vermillion Files Amended Plan of Reorganization and Exchanges Debt 2Vermillion Files Amended Plan of Reorganization and Exchanges Debt 3Striking Red Cross Workers Raise Public Awareness of Unsafe Working Conditions 2SHPS Receives Re Accreditation from URAC for Consumer Education and Support Program 61629 1SHPS Receives Re Accreditation from URAC for Consumer Education and Support Program 61629 2Sleep HealthCenters Launches SleepPartners 28TM 29 Network 61626 1Sleep HealthCenters Launches SleepPartners 28TM 29 Network 61626 2Viron reports positive Phase II data in Acute Coronary Syndromes 28ACS 29 patients 14901 1Viron reports positive Phase II data in Acute Coronary Syndromes 28ACS 29 patients 14901 2Viron reports positive Phase II data in Acute Coronary Syndromes 28ACS 29 patients 14901 3Viron reports positive Phase II data in Acute Coronary Syndromes 28ACS 29 patients 14901 4
...g. 10 Solvay Pharmaceuticals, Inc. and,Wyeth Phar...nounced today the,receipt of an action letter from...sponse to the New Drug Application (NDA) for bifep... for the acute treatment of,schizophrenia, as well...Agency stated that the drug was not approvable at ...
...al benefits are many, clinical studies are few, N...oday revealed that a limited amount of clinical re...ver-the-counter (OTC) anti-aging,products. The stu...he,Aesthetic Surgery Journal, the official peer-re...ic Plastic Surgery (ASAPS). OTC anti-aging produc...
Other Medicine Technology:Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia 2Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia 3OTC Anti-Aging Products: Hype or Hope? 2
(Date:12/4/2009)...PRNewswire/ -- Substantial progress has been made ...,s ability to diagnose and treat epilepsy and its ...gement has not reached most of the 50 million peop...three million people in the United States who have...ter, M.D., president of the American Epilepsy Soci...
(Date:12/4/2009)...er Applauds Historic Effort but Points out Potenti...in Final Health Care Reform ,, NEW YORK, Dec....urnal of Medicine today published a Perspective ...thored by Irwin Redlener, M.D., president, Childre...Disaster Preparedness and Professor of Clinical Po...
(Date:12/4/2009)...rged for at-risk patient groups , , FRID...ers, particularly Ewing sarcomas and central nervo...e, U.S. researchers have found. , The study aut... of the most common pediatric cancers who were enr... The researchers found that the overall cancer rec...
(Date:12/4/2009)... come back during winter isn,t known, CDC says, ,...e number of states reporting widespread swine flu ...rom a high of 48 just two weeks ago, a U.S. health...of H1N1 swine flu vaccine continues to increase, D... for Disease Control and Prevention, said during a...
(Date:12/4/2009)...wering drugs known as statins are among the most p... researchers at Fred Hutchinson Cancer Research Ce...transplant patients from one of the most serious c...aft-versus-host disease, or GVHD. The findings are...al Blood . , In a retrospective study of 567 pat...
Breaking Medicine News(10 mins):Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 2Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 3Health News:Epilepsy Patients Caught in Treatment Gap and Not Getting State-of-the-Art Care 4Health News:New England Journal of Medicine Perspective by Irwin Redlener, MD, Addresses Health Care Reform 2Health News:Swine Flu Continues to Wane 2Health News:Cholesterol-lowering drugs also may protect stem cell transplant patients from GVHD 2
...R, Pa., Dec. 16 Herley Industries, Inc.,(Nasdaq: ...First Quarter of,Fiscal Year 2009. , A Confe...n Time on,Wednesday, December 17, 2008. Interested...o begin on December 17, 2008,two hours after compl...
...inds roadblocks still plague female practitioners,...The number of female cardiologists in the United S...entation of women in the profession and discrimina...is about the same, women account for fewer than 20...
...ients on antiepileptics need to be monitored for i...c. 16 (HealthDay News) -- The U.S. Food and Drug A...g a label warning on heightened suicide risk for u... box" warning on this class of drugs, which includ...
...achieves $100 million in revenues through early De...st, Inc. (NYSE: MED ), a leading provider of eas...ght loss programs, today announced the company wil...illion to $92.0 million. The Company now expects r...
...N, Va., Dec. 16 The Centers for Faith-Based and ...national Development (USAID) and the Department of...Monday to foster greater collaboration in disaster... Recovery brought together faith-based and commun...
...Ohio, Dec. 16 Join STERIS Isomedix Services for...topics critical to success in,medical device steri...l/ ). The,event, being held in San Jose, Californ...uch more. , In addition to the TechTeam expe...
Other Medicine News:Health News:Herley Reports 1st Quarter Results 2Health News:Herley Reports 1st Quarter Results 3Health News:Herley Reports 1st Quarter Results 4Health News:Herley Reports 1st Quarter Results 5Health News:Herley Reports 1st Quarter Results 6Health News:Herley Reports 1st Quarter Results 7Health News:Herley Reports 1st Quarter Results 8Health News:Among Cardiologists, Women Cite Discrimination 2Health News:FDA Adds Suicide Warning to Epilepsy Drugs 2Health News:FDA Adds Suicide Warning to Epilepsy Drugs 3Health News:Medifast to Exceed Revenue Guidance for 2008 2Health News:Medifast to Exceed Revenue Guidance for 2008 3Health News:Medifast to Exceed Revenue Guidance for 2008 4Health News:USAID and DHS Host Summit on Partnering with Faith-Based and Community Organizations for Disaster Response 2Health News:STERIS Isomedix Services Offers Medical Device Sterilization Seminar 2
Model 300 Pulse Oximeter
Model 100 Pulse Oximeter
... The MiniCorr Digital Hand-Held Pulse Oximeter pro... from neonate to adult. The device is battery or ...s visible and audible alarm signals, and an infrar...rubber boot is also available for added protection...
... The Autocorr Pulse Oximeter with SAC (Serial Auto...unique patented software to extract SpO 2 , pulse ...cost-effective compact monitor incorporates clinic...tures, and a data log or trend printout of stored ...
Medicine Products: